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INTRODUCTION
DNA amplification is a common mechanism used by cancer cells to up-regulate the activity of critical genes associated with tumor development and progression [1, 2] .
In breast cancer, a number of discrete amplicons have been identified, involving ERBB2 (17q12), MYC (8q24), CCND1 (11q13), AIB1 (20q13) and FGFR (10q26) genes [3, 4, 5, 6, 7] . The most common regions of increased DNA copy number in breast cancer as determined by Comparative Genomic Hybridization (CGH) include the chromosome arm 1q, where an unambiguous target gene has not been identified yet [8, 9] . Although regional genomic copy number amplifications frequently increase the expression of relevant oncogenes, they may also serve as an indicator of genomic instability [10] . As such, presence of one or several gene amplifications may have prognostic significance.
MUC1 oncoprotein is aberrantly overexpressed in approximately 90% of human breast cancers [11, 12, 13] , which has been associated with cell adhesion inhibition as well as increased metastatic and invasive potential of tumor cells [14] . This over-expression allows MUC1 to interact with members of the ERBB family of receptor tyrosine kinases [15] . In addition, the MUC1 cytoplasmic domain, which comprises the last 72-aa, also interacts with diverse effectors that have been linked to transformation, such as c-Src, β-catenin, and IKβ /NF-KB [15, 16, 17] .
Several studies have shown that MUC1 over-expression is in part due to transcriptional regulatory events [18, 19, 20, 21] . Furthermore, MUC1 regulation has been also associated to epigenetic changes in cancer cells [22] . However, the importance of gene amplification as a mechanism leading to the increase of MUC1 expression in breast cancer has been poorly characterized. In an early study, Bièche and Liderau (1997) have postulated a concordance between MUC1 mRNA expression and gene dosage in breast carcinomas [23] . Similar observations were further reported affecting ovary, thyroid and   1  2  3  4  5  6  7  8  9  10  11  12  13  14  15  16  17  18  19  20  21  22  23  24  25  26  27  28  29  30  31  32  33  34  35  36  37  38  39  40  41  42  43  44  45  46  47  48  49  50  51  52  53  54  55  56  57  58  59  60  61  62  63  64  65   4 gastric carcinomas [24, 25, 26] . Interestingly, a recent array-CGH study coupled to genome-wide transcriptome map showed a cluster of genes, located at 1q21.3-1q22, exhibiting the strongest association between copy number and gene expression in primary breast carcinomas [27] . In addition, in silico analysis of the transcriptomic profile, based on our previously published SAGE (Serial Analysis of Gene Expression) data sets [28, 29] , showed that MUC1 is the most frequently up-regulated gene at 1q21.3-1q22 chromosomal region in primary invasive breast carcinomas. Thus, the possible association between MUC1 expression and gene amplification could reveal novel information about MUC1 as a predictive breast cancer gene. The aim of this study was to evaluate the role of MUC1 gene amplification and protein expression in human breast cancer progression.
MATERIAL AND METHODS

Tissue samples and cell lines
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Cell culture
The estrogen-dependent breast cancer cell lines MCF7, T47D and ZR75-1 were grown in RPMI-1640 medium (Gibco, Gaithersburg, MD, USA) supplemented with 10% (v/v) FBS (Bioser, Buenos Aires, Argentina), 10 IU/ml penicillin G, and 10 μg/ml streptomycin. The human diploid fibroblast cell strain MRC5 was grown in Minimal
Essential Medium (Gibco, Gaithersburg, MD, USA), supplemented with non-essential amino acids and 0.1% sodium pyruvate (Gibco, Gaithersburg, MD, USA). Cells cultures were harvested by rinsing the monolayer with cold lysis buffer; the cell suspension was centrifuged and the pellet recovered before tissue digestion (see below).
DNA extraction and purification
Paraffin embedded samples from breast tissues were processed by routine techniques for histological analysis. Briefly, four 10 µm paraffin embedded tissue from each biopsy were used for DNA extraction. Tissue digestion was performed by incubating in extraction buffer (1M Tris-HCl, ph 8; 1mM EDTA; 1% Tritón; 0.5% Tween) with proteinase K at 56° C overnight. Finally, DNA from tissue samples and cell lines was purified by phenol-chloroform-isoamylalcohol method (25:24:1) followed by ethanol precipitation as was previously described [30] . The DNA was resuspended in distilled water. DNA concentration was measured on the Nanodrop ® spectrophotometer and adjusted to 30ng/µl.
Real-Time Quantitative PCR analysis (Q-PCR)
DNA Q-PCR was done using the PerfeCta SYBR  Green SuperMix (Quanta Biosciences) and the Stratagene MX30005P Real-Time PCR System. The efficiencycorrected comparative ∆∆C t method was applied, and the ∆C t of a human normal diploid is located at the chromosome region 1p35.2. The MUC1 amplicon (86 bp) ( Figure 1A) does not include the tandem repeat region present within the MUC1 gene and PUM1
gene has been well established as a reference control in breast cancer samples [31] .
The PCR reactions were performed using 12.5 µl of the SuperMix (Quanta 
Immunohistochemistry analysis (IHC)
IHC was performed according to standard procedures as previously reported [32] .
Briefly, sections of 4 µm thick were cut from block paraffin tissue samples, de-waxed and rehydrated using xylene and ethanol, respectively. Endogenous peroxidase activity was blocked by treatment with 0.3% H 2 O 2 (MERCK, Germany) in methanol. Then, 
Western-blot analysis (WB)
Homogenates from breast tissue samples were filtered through a mesh and centrifuged at 1500 g, 4 °C for 15 min; the resulting supernatants were subjected to SDS-PAGE and WB analysis. Electrophoretic separation of proteins was performed with discontinuous 4% stacking-10% resolving polyacrylamide gels under reductive conditions employing a miniVE Vertical Electrophoresis System (Amersham Biosciences Corp.). Gels were transferred to nitrocellulose membranes, which were blocked with 3% dry milk in PBS/Tween-20 (0.05%) at 4-8°C for 3-h and then washed in PBS/Tween-20 (0.05%). 
Bioinformatics and statistical analysis.
To perform the comparative analysis of the transcriptomic profiles in a set of normal and breast cancer samples, we combined 6 normal breast SAGE libraries -available in public databases (http://cgap.nci.nih.gov/cgap.html)-with 23 invasive breast cancer SAGE libraries previously reported by us [29] . To compare the 29 SAGE libraries, we utilized a modified t-test as was previously described [28] . This analysis allowed us to identify SAGE tags with significantly different expression levels between normal and invasive ductal carcinomas (p<0.01).
To enable visualization and illustration of the 1q21-q23 chromosome region in MCF7, T47D and ZR75-1 breast cancer cell lines from Pollack's and Chin's array-CGH data [9, 27], we used the VAMP software (Visualization and Analysis of array-CGH, transcriptome and other Molecular Profiles) (http://bioinfo-out.curie.fr/actudb) (33) .
The association between MUC1 gene amplification, protein over-expression and histological status of the samples was assessed by Fisher's exact test: the two way contingency tables were the result of defining the variables amplification status, which was codified as 0 to non amplified samples and 1 to amplified samples, and protein expression that was coded according to the grade of staining intensity obtained by IHC 
RESULTS
We analyzed the global gene expression profile in a set of normal and breast cancer SAGE libraries (Serial Analysis of Gene Expression) previously published by us [28, 29] . Interestingly, we identified the MUC1 gene among the most highly up-regulated 1  2  3  4  5  6  7  8  9  10  11  12  13  14  15  16  17  18  19  20  21  22  23  24  25  26  27  28  29  30  31  32  33  34  35  36  37  38  39  40  41  42  43  44  45  46  47  48  49  50  51  52  53  54  55  56  57  58  59  60  61  62  63  64 
DISCUSSION
Breast cancer progresses as a result of the accumulation of genomic changes, which is thought to underlie the clonal evolution of cancer disease [35] . Moreover, in a significant subset of human breast cancers, as in other solid tumors, gene amplification is an important mechanism for oncogene activation during tumor progression [9] .
The MUC1 oncogene, located at the 1q21.3-q22 chromosomal region, is markedly overexpressed in breast cancer and has been associated with aggressive tumor behavior [14] . In this study, in silico analysis of previously published SAGE databases [28, 29] lead us to identify MUC1 gene as the most up-regulated transcript from the 1q21.3-q22 chromosomal region in invasive breast carcinomas. Indeed, up-regulation of MUC1 appears to be specifically associated with adenocarcinomas from various sources, which has been correlated with increased metastatic potential and poor prognosis [14, 25] .
Many studies have revealed that the increase of MUC1 expression is related with transcriptional regulatory events or epigenetic changes [19, 18, 20, 22] . However, in an early study, Bièche and Liderau [23] found a concordance between the MUC1 DNA relative copy numbers and MUC1 mRNA expression levels in primary breast carcinomas, suggesting a gene dosage effect. Interestingly, in a wide variety of carcinoma types including ovary, papillary thyroid and gastric cancers, MUC1 amplification and over-expression was also found [25, 24, 26] . These observations support a functional role of MUC1 as part of the frequent DNA copy number gains observed in a variety of epithelial neoplasias and possibly other malignancies [36] .
In this study, we performed a Q-PCR and IHC analyses on malignant, benign and normal breast epithelial tissue samples and breast cancer cell lines, in order to determine whether gene amplification is a mechanism leading to MUC1 over-expression. Q-PCR has proven to be a very powerful tool to analyze gene copy variations in cancer [25, 37] . 1  2  3  4  5  6  7  8  9  10  11  12  13  14  15  16  17  18  19  20  21  22  23  24  25  26  27  28  29  30  31  32  33  34  35  36  37  38  39  40  41  42  43  44  45  46  47  48  49  50  51  52  53  54  55  56  57  58  59  60  61  62  63  64  65 13 By this method, we detected MUC1 gene amplification in 12% of benign lesions and 38% of invasive breast carcinomas. We also found gene amplification in the T47D breast cancer cell line as was previously evidenced by array-CGH analysis. The results of our study show that MUC1 gene copy number increases in invasive breast samples and in the hyperplasic lesions, which means that this gene could have an early causal role in the breast cancer development.
To determine whether MUC1 gene amplification status is also correlated with protein 1  2  3  4  5  6  7  8  9  10  11  12  13  14  15  16  17  18  19  20  21  22  23  24  25  26  27  28  29  30  31  32  33  34  35  36  37  38  39  40  41  42  43  44  45  46  47  48  49  50  51  52  53  54  55  56  57  58  59  60  61  62  63  64  65 14 carcinomas showed over-expression of MUC1 in the absence of gene amplification, suggesting that the up-regulation of MUC1 expression in these samples would be mediated by another mechanism. Interestingly, array-CGH / DNA microarray evidence is available reporting amplification and over-expression of the chromosomal region 1q21.3-q22 (the same region to which MUC1 maps) in breast cancer cell lines and primary breast carcinomas [27] . Moreover, a genome-wide transcriptome map revealed clusters of genes located at 1q21 exhibiting nonrandom increased expression in breast cancer cells [41] .
CONCLUSION
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